BACKGROUND: The head and neck is the most common site of mucosal melanoma, a cancer with poor prognosis. In contrast to cutaneous melanoma, mucosal melanoma of the head and neck (MMHN) is uncommon, with limited data regarding outcomes and prognostic factors drawn from small, single-institution case series. In order to identify factors predictive of survival, we analyzed MMHN outcomes in a large US cohort. METHODS: MMHN cases (n = 815) diagnosed in the USA between 1973 and 2007 were analyzed in the Surveillance, Epidemiology, and End Results registry, and cause of death was individually determined in 778 (95.5%) cases. Kaplan-Meier survival analysis and Cox proportional hazards regression were used to analyze prognostic variables. RESULTS: Disease-specific survival status was determined in 778 (95.5%) cases. The 5- and 10-year rates of overall survival (OS) were 25.2 and 12.2%; disease-specific survival (DSS), 32.4 and 19.3%. On multivariable analysis, anatomic primary site was an independent predictor of OS and DSS, with tumors in the nasal cavity and oral cavity associated with survival superior to tumors in the nasopharynx and paranasal sinuses. Age > 70 years, tumor size, nodal status, and distant metastasis status were additional independent predictors of poorer survival. CONCLUSIONS: In this large cohort of patients with MMHN, we have identified several novel factors robustly predictive of overall and melanoma-specific survival.
BACKGROUND: The head and neck is the most common site of mucosal melanoma, a cancer with poor prognosis. In contrast to cutaneous melanoma, mucosal melanoma of the head and neck (MMHN) is uncommon, with limited data regarding outcomes and prognostic factors drawn from small, single-institution case series. In order to identify factors predictive of survival, we analyzed MMHN outcomes in a large US cohort. METHODS:MMHN cases (n = 815) diagnosed in the USA between 1973 and 2007 were analyzed in the Surveillance, Epidemiology, and End Results registry, and cause of death was individually determined in 778 (95.5%) cases. Kaplan-Meier survival analysis and Cox proportional hazards regression were used to analyze prognostic variables. RESULTS: Disease-specific survival status was determined in 778 (95.5%) cases. The 5- and 10-year rates of overall survival (OS) were 25.2 and 12.2%; disease-specific survival (DSS), 32.4 and 19.3%. On multivariable analysis, anatomic primary site was an independent predictor of OS and DSS, with tumors in the nasal cavity and oral cavity associated with survival superior to tumors in the nasopharynx and paranasal sinuses. Age > 70 years, tumor size, nodal status, and distant metastasis status were additional independent predictors of poorer survival. CONCLUSIONS: In this large cohort of patients with MMHN, we have identified several novel factors robustly predictive of overall and melanoma-specific survival.
Authors: John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian Journal: N Engl J Med Date: 2005-11-17 Impact factor: 91.245
Authors: Marco Krengli; Laura Masini; Johannes H A M Kaanders; Philippe Maingon; Swan Bing Oei; Abderrahim Zouhair; Enis Ozyar; Martine Roelandts; Maurizio Amichetti; Mathieu Bosset; René-Olivier Mirimanoff Journal: Int J Radiat Oncol Biol Phys Date: 2006-05-02 Impact factor: 7.038
Authors: Mauricio A Moreno; Dianna B Roberts; Michael E Kupferman; Franco DeMonte; Adel K El-Naggar; Michelle Williams; David S Rosenthal; Ehab Y Hanna Journal: Cancer Date: 2010-05-01 Impact factor: 6.860
Authors: Snehal G Patel; Manju L Prasad; Margarita Escrig; Bhuvanesh Singh; Ashok R Shaha; Dennis H Kraus; Jay O Boyle; Andrew G Huvos; Klaus Busam; Jatin P Shah Journal: Head Neck Date: 2002-03 Impact factor: 3.147
Authors: Abraham J Wu; Jennifer Gomez; Joanne E Zhung; Kelvin Chan; Daniel R Gomez; Suzanne L Wolden; Michael J Zelefsky; Jedd D Wolchok; Richard D Carvajal; Paul B Chapman; Richard J Wong; Ashok R Shaha; Dennis H Kraus; Jatin P Shah; Nancy Y Lee Journal: Am J Clin Oncol Date: 2010-06 Impact factor: 2.339
Authors: Fernando López; Juan P Rodrigo; Antonio Cardesa; Asterios Triantafyllou; Kenneth O Devaney; William M Mendenhall; Missak Haigentz; Primož Strojan; Phillip K Pellitteri; Carol R Bradford; Ashok R Shaha; Jennifer L Hunt; Remco de Bree; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito Journal: Head Neck Date: 2015-05-22 Impact factor: 3.147
Authors: Saïd C Azoury; Joseph G Crompton; David M Straughan; Nicholas D Klemen; Emily S Reardon; Tatiana H Beresnev; Marybeth S Hughes Journal: Int J Surg Case Rep Date: 2015-04-01
Authors: David M Marcus; Rebecca P Marcus; Roshan S Prabhu; Taofeek K Owonikoko; David H Lawson; Jeffrey Switchenko; Jonathan J Beitler Journal: J Skin Cancer Date: 2012-12-02